Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.Medical and Pediatric Oncology.  65:e27420. 2018
2018 Red blood cell transfusion therapy for sickle cell patients with frequent painful events.Medical and Pediatric Oncology.  65:e27423. 2018
2018 Outcomes in Mild to Moderate Isolated Thrombocytopenia.Pediatrics.  142. 2018
2016 A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.Journal of Immunology.  196:2492-2503. 2016
2015 Health-related Quality of Life in Infants With Sickle Cell Disease.Journal of Pediatric Hematology/Oncology.  37:590-594. 2015
2015 Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.Journal of Neurosurgery: Pediatrics.  16:64-73. 2015
2015 Exploring Adult Care Experiences and Barriers to Transition in Adult Patients with Sickle Cell Disease.International journal of hematology & therapy.  1. 2015
2015 Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.Journal of Blood Medicine.  6:285-290. 2015
2015 Patient-centered approach to designing sickle cell transition education.Journal of Pediatric Hematology/Oncology.  37:43-47. 2015
2014 PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity.Medical and Pediatric Oncology.  61:171-177. 2014
2013 PedsQL™ sickle cell disease module: feasibility, reliability, and validity.Medical and Pediatric Oncology.  60:1338-1344. 2013
2012 Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.Arthritis and Rheumatism.  64:1263-1271. 2012
2012 Barriers in transition from pediatrics to adult medicine in sickle cell anemia.Journal of Blood Medicine.  3:105-112. 2012
2010 Single institution series of nodular fasciitis in children.Journal of Pediatric Hematology/Oncology.  32:354-357. 2010

Investigator On

  • Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT Trial)  awarded by ALL CHILDREN'S RESEARCH INSTITUTE 2017 - 2021
  • Project Everychild APEC14B1  awarded by CHILDREN'S ONCOLOGY GROUP 2015 - 2020
  • AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2020
  • A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2014 - 2020
  • St. Baldrick's Foundation Supplemental Reimbursement  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2018 - 2020
  • Per Case Reimbursement: COG NCORP Research Base  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2019
  • Private Grant  awarded by SANCILIO & COMPANY, INC. 2017 - 2019
  • AAML 1031 - Bayer  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2017 - 2019
  • COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2018 - 2019
  • Per Case Reimbursement: COG NCORP Research Base  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2014 - 2018
  • St. Baldricks Fdn Supplemental Reimbursement  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2018
  • AHOD1331 A Randomized Phase III Study of Brentuximab Vedotin (IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2016 - 2018
  • Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2013 - 2017
  • The Kids - DOTT Trial  awarded by ALL CHILDREN'S RESEARCH INSTITUTE 2015 - 2017
  • CTSU: Phase II Supplemental Payments (N02-CM-62212)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2017
  • Novel Methods to Detect Gene-Environment Interactions in Treatment-Related Brain Tumors Among Childhood Cancer Survivors  awarded by University of Wisconsin-Milwaukee 2015 - 2016
  • BIQSFP-COG AALL1131 11XS189 Per Case Reimbursement  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2015
  • COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2014 - 2015
  • Private Grant  awarded by MILLENNIUM PHARMACEUTICALS, INC. 2014
  • AAML 1031 - A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD  awarded by CHILDREN'S ONCOLOGY GROUP 2014
  • Private Grant  awarded by TERUMO BCT, INC. 2012 - 2013
  • Education And Training

  • Bachelor's Degree in Political Science and Government, University of Alabama at Birmingham
  • Doctor of Medicine, University of Alabama at Birmingham
  • UAB Hospital, Internship 2007
  • UAB Hospital, Residency 2009
  • UAB Hospital, Postdoctoral Fellowship 2012
  • Full Name

  • Christina Bemrich-Stolz